1 |
Tice, T.R., Tabibi, E., 1991. Parenteral drug delivery: injectables. Treatise on controlled drug delivery: fundamentals optimization, applications, Marcel Dekker, New York, 315-339.
|
2 |
Weert, M., Hennink, W.E., Jiskoot, W., 2000. Protein instability in poly (lactic-co-glycolic acid) microparticles. Pharm. Res. 17, 1159-1167.
DOI
|
3 |
Vert, M., Mauduit, J., Li, S., 1994. Biodegradation of PLA/GA polymers: increasing complexity. Biomaterials 15, 1209-1213.
DOI
|
4 |
Xi, K., Tabata, Y., Uno, K., Yoshimoto, M., Kishida, T., Sokawa, Y., Ikada, Y., 1996. Liver targeting of interferon through pullulan conjugation. Pharm. Res. 13, 1846-1850.
DOI
|
5 |
Yang, H.J., Park, I.S., Na, K., 2009. Biocompatible microspheres based on acetylated polysaccharide prepared from water-inoil- in-water (W1/O/W2) double-emulsion method for delivery of type II diabetic drug (exenatide). Colloids Surf. Physicochem. Eng. Aspects 340, 115-120.
DOI
|
6 |
Means, G.E., Feeney, R.E., 1995. Reductive alkylation of proteins. Anal. Biochem. 224, 1-16.
DOI
|
7 |
Morimoto, K., Chono, S., Kosai, T., Seki, T., Tabata, Y., 2008. Design of cationic microspheres based on aminated gelatin for controlled release of peptide and protein drugs. Drug Deliv. 15, 113-117.
DOI
|
8 |
Na, D.H., DeLuca, P.P., 2005. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly (D, L-lactide-co-glycolide). Pharm. Res. 22, 736-742.
DOI
|
9 |
Noga, D.E., Petrie, T.A., Kumar, A., Weck, M., García, A.J., Collard, D.M., 2008. Synthesis and modification of functional poly (lactide) copolymers: Toward biofunctional materials. Biomacromolecules 9, 2056-2062.
DOI
|
10 |
Park, K.H., Kang, D.M., Na, K., 2006. Physicochemical characterization and carcinoma cell interaction of selforganized nanogels prepared from polysaccharide/biotin conjugates for development of anticancer drug carrier. J. Microbiol. Biotechnol. 16, 1369-1376.
|
11 |
Park, W., Na, K., 2009. Dermatan sulfate as a stabilizer for protein stability in poly (lactide-co-glycolide) depot. Biotechnol. Bioprocess Eng. 14, 668-674.
DOI
|
12 |
Shao, P.G., Bailey, L.C., 2000. Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics. Pharm. Dev. Technol. 5, 1-9.
DOI
|
13 |
Sinha, V., Trehan, A., 2003. Biodegradable microspheres for protein delivery. J. Controlled Release 90, 261-280.
DOI
|
14 |
Houchin, M., Topp, E., 2008. Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. J. Pharm. Sci. 97, 2395-2404.
DOI
ScienceOn
|
15 |
Song, H.C., Na, K., Park, K.H., Shin, C.H., Bom, H.S., Kang, D.M., Kim, S.W., Lee, E.S., Lee, D.H., 2006. Intratumoral administration of rhenium-188-labeled pullulan acetate nanoparticles (PAN) in mice bearing CT-26 cancer cells for suppression of tumor growth. J. Microbiol. Biotechnol. 16, 1491- 1498.
|
16 |
Fu, K., Harrell, R., Zinski, K., Um, C., Jaklenec, A., Frazier, J., Lotan, N., Burke, P., Klibanov, A.M., Langer, R., 2003. A potential approach for decreasing the burst effect of protein from PLGA microspheres. J. Pharm. Sci. 92, 1582-1591.
DOI
|
17 |
Heller, J., 1980. Controlled release of biologically active compounds from bioerodible polymers. Biomaterials 1, 51-57.
DOI
|
18 |
Jalil, R., Nixon, J., 1990. Biodegradable poly (lactic acid) and poly (lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J. Microencapsul. 7, 297-325.
DOI
|
19 |
Kim, H., Na, K., 2010. Evaluation of succinylated pullulan for long-term protein delivery in poly (lactide-co-glycolide) microspheres. Macromol. Res. 18, 812-819.
DOI
|
20 |
Kitchell, J.P., Wise, D.L., 1985. Poly (lactic/glycolic acid) biodegradable drug-Polymer matrix systems. Methods Enzymol. 112, 436-448.
DOI
|
21 |
Leathers, T., 2003. Biotechnological production and applications of pullulan. Appl. Microbiol. Biotechnol. 62, 468-473.
DOI
|
22 |
Lee, E.S., Park, K.H., Kang, D., Park, I.S., Min, H.Y., Lee, D.H., Kim, S., Kim, J.H., Na, K., 2007. Protein complexed with chondroitin sulfate in poly (lactide-co-glycolide) microspheres. Biomaterials 28, 2754-2762.
DOI
|
23 |
Domb, A.J., Turovsky, L., Nudelman, R., 1994. Chemical interactions between drugs containing reactive amines with hydrolyzable insoluble biopolymers in aqueous solutions. Pharm. Res. 11, 865-868.
DOI
|
24 |
Lewis, D.H., 1990. Controlled release of bioactive agents from lactide/ glycolide polymers. Drugs Pharmaceut. Sci. 45, 1-41.
|
25 |
Liu, C., Sun, R., Zhang, A., Ren, J., Wang, X., Qin, M., Chao, Z., Luo, W., 2007. Homogeneous modification of sugarcane bagasse cellulose with succinic anhydride using a ionic liquid as reaction medium. Carbohydr. Res. 342, 919-926.
DOI
|
26 |
Anderson, J.M., Shive, M.S., 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Del. Rev. 28, 5-24.
DOI
|
27 |
Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L.H., Langer, R., 1991. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharm. Res. 8, 713-720.
DOI
|
28 |
Couvreur, P., Puisieux, F., 1993. Nano-and microparticles for the delivery of polypeptides and proteins. Adv. Drug Del. Rev. 10, 141-162.
DOI
|